Profile

Dr Lisa Page is a partner in the intellectual property team in Birmingham who specialises in the life sciences sector. With a client base ranging from pharmaceutical companies to biotech start-ups and spin-outs, she advises on all stages of the drug development pathway including registration, regulatory, pharmacovigilance, pre-clinical and clinical development as well as on multi-party collaborations and spin-outs. She has particular experience in the development stage of new products, covering pipeline, co-development, out-licensing and in-licensing arrangements.

Alongside intellectual property and life sciences, Lisa has a separate practice focusing on state aid as it applies to research and development including the R&D&I Framework and GBER. She has advised on a number of high value grant funded and research infrastructure projects in addition to providing guidance to research organisations more generally on state aid compliance.

Lisa has a PhD in molecular microbiology and direct practical experience of working in the pharmaceutical industry before re-training as a solicitor. Her scientific background provides a specialist insight into the issues faced by her clients and enables her to speak their language when advising on development programmes and the exploitation of life science technologies. She has held a number of in-house legal roles, including at the Energy Technologies Institute and Coventry University, and was recently appointed director of the West Midlands Health Technology Cluster Organisation.